Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention.

Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention.

Show other versions (1)

<h4>Background</h4>The safety and efficacy profile of bivalirudin has not been examined in a randomised controlled trial of patients undergoing rescue PCI.<h4>Objectives</h4>We conducted an open-label, multi-centre, randomised controlled trial to compare bivalirudin with hepa...

Full description

Bibliographic Details
Main Authors: Amir Faour, Nicholas Collins, Trent Williams, Arshad Khan, Craig P Juergens, Sidney Lo, Darren L Walters, Derek P Chew, John K French
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0259148

Internet

https://doi.org/10.1371/journal.pone.0259148

Similar Items